Vivek K. Jayaraman
Net Worth
Last updated:
What is Vivek K. Jayaraman net worth?
The estimated net worth of Mr. Vivek K. Jayaraman is at least $8,295,573 as of 14 Mar 2024. He owns shares worth $1,045,597 as insider, has earned $1,330,856 from insider trading and has received compensation worth at least $5,919,120 in Cerus Corporation.
What is the salary of Vivek K. Jayaraman?
Mr. Vivek K. Jayaraman salary is $739,890 per year as Chief Operating Officer in Cerus Corporation.
How old is Vivek K. Jayaraman?
Mr. Vivek K. Jayaraman is 50 years old, born in 1975.
What stocks does Vivek K. Jayaraman currently own?
As insider, Mr. Vivek K. Jayaraman owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Cerus Corporation (CERS) | Chief Operating Officer | 878,653 | $1.19 | $1,045,597 |
What does Cerus Corporation do?
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Vivek K. Jayaraman insider trading
Cerus Corporation
Mr. Vivek K. Jayaraman has made 13 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 26,794 units of CERS stock worth $52,891 on 14 Mar 2024.
The largest trade he's ever made was exercising 103,733 units of CERS stock on 12 Mar 2021. As of 14 Mar 2024 he still owns at least 878,653 units of CERS stock.
Cerus key executives
Cerus Corporation executives and other stock owners filed with the SEC:
- Dr. Laurence M. Corash (81) Co-Founder & Chief Scientific Officer
- Dr. Richard J. Benjamin (65) Chief Medical Officer
- Mr. Kevin D. Green (53) Vice President of Fin. & Chief Financial Officer
- Mr. Vivek K. Jayaraman (50) Chief Operating Officer
- Mr. William M. Greenman (58) Pres, Chief Executive Officer & Director